Understanding a Protective Brain Cell Type in Alzheimer's Disease
Interrogation of a human microglia phenotype associated with Alzheimer's disease
This research explores a specific type of brain cell, called microglia, that may help protect against Alzheimer's disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11127513 on NIH RePORTER |
What this research studies
Our brains contain special immune cells called microglia that normally keep things healthy, but they can become unbalanced in diseases like Alzheimer's. Many genes linked to Alzheimer's are active in these microglia, suggesting they could be a key target for new treatments. We've found different types of microglia in the aging human brain, and one particular type seems to be linked to less severe Alzheimer's symptoms and pathology. This project aims to understand how this specific protective microglia type works and how it might help fight Alzheimer's disease.
Who could benefit from this research
Good fit: This foundational research is not recruiting patients directly but aims to benefit individuals at risk for or living with Alzheimer's disease in the future.
Not a fit: Patients seeking immediate treatment or direct clinical intervention will not find benefit from this basic science project.
Why it matters
Potential benefit: If successful, this work could identify new ways to develop preventive or disease-modifying therapies for Alzheimer's disease by targeting these protective brain cells.
How similar studies have performed: This project builds upon prior single-cell RNA sequencing studies that have successfully identified distinct microglia subpopulations in the human brain.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Olah, Marta — Columbia University Health Sciences
- Study coordinator: Olah, Marta
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.